vimarsana.com
Home
Live Updates
Alex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxiety : vimarsana.com
Alex Therapeutics presents results from digital therapeutic pilot study showing nearly 50% reduction in anxiety
/PRNewswire/ -- Alex Therapeutics is a DTx Software-as-a-medical-device (SaMD) manufacturer developing and licensing digital app-based therapies for multiple...
Related Keywords
Germany ,
Sweden ,
Stockholm ,
Swedish ,
John Drakenberg ,
Gergana Almquist ,
Vicore Pharma ,
Jessica Shull ,
Sebastian Blendow ,
Pfizer ,
Linkedin ,
Global Partnership ,
Vicore Pharma Holding ,
Digital Therapeutic ,
Alex Therapeutics ,
Idiopathic Pulmonary Fibrosis ,
Generalized Anxiety Disorder ,
Digital Therapeutics ,
Cognitive Behavioural Therapy ,
Pulmonary Fibrosis ,
Nasdaq Stockholm ,
vimarsana.com © 2020. All Rights Reserved.